<DOC>
	<DOCNO>NCT01380457</DOCNO>
	<brief_summary>The purpose study compare rate extent absorption Dronabinol 10 mg capsule verse Marinol .</brief_summary>
	<brief_title>Bioavailability Study Dronabinol Capsules 10 mg Under Fasting Conditions</brief_title>
	<detailed_description>To compare plasma level dronabinol ( delta-9-tetrahydrocannabinol ) principle active metabolite 11-OH-delta-9-tetrahydrocannabinol level produce administration test formulation produce administration market reference product , fasted condition .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Dronabinol</mesh_term>
	<criteria>Healthy volunteer , 18 55 year age Subjects must within 18 29.9 kilograms/m2 per BMI General good health determine medical history physical examination within 30 day prior start study Blood chemistry , hematology , urinalysis test perform within 30 day prior start study No participation investigational drug study donation blood within 30 day prior start study At screen , subject must blood pressure pulse rate within specify range No grapefruit juice grapefruitcontaining product least 72 hour prior drug administration , period . Subjects query checkin period consumption grapefruit juice grapefruit containing product . Results record reported final report . No alcohol consumption least 24 hour prior drug administration , period No caffeine xanthine consumption 48 hour prior prior drug administration , period No prescription drug ( exclude hormonal contraceptive ) within 14 day prior drug administration , period Subjects refrain take OTC preparation , and/or nutritional supplement within 7 day prior drug administration , period . Subjects shall refrain take herbal remedy within 14 day prior drug administration , throughout study period Female subject must pregnant nursing ; must surgically sterile ; one year postmenopausal ; hormonal contraceptive agent ) , diaphragm condom spermicidal foam jelly , IUD least 3 month prior drug administration agree use method contraception least 1 month last drug administration Negative serum pregnancy test screen negative urine pregnancy test prior drug administration , period Negative HIV 1 , hepatitis B surface antigen , urine screen drug abuse within 30 day prior start study Disease condition could impact interpretation study result condition treatment would contraindicate per currently approve product label Subjects follow condition : use prescription OTC medication within 14 day study initiation positive urine test illicit drug participate clinical investigation within past 30 day clinically significant allergy drug food , ot condition might place increase risk complication</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>bioequivalence</keyword>
	<keyword>dronabinol</keyword>
	<keyword>fast</keyword>
</DOC>